Demant A/S

DEMANT · Nasdaq Copenhagen · Healthcare

314.00DKK −0.1%last day

Price as of 2 October 2026

The price over the past year, with dividends: +39.6%

Performance

1 month

+6.9%

1 year

+39.6%

3 years, per year

+2.7%

5 years, per year

−2.5%

Largest fall, 3 years

−52.5%

Below the peak now

−19.4%

Volatility, 1 year

33.4%

Return with dividends reinvested.

Key figures

P/E

40.0

P/B

5.8

Dividend yield

0.0%

Return on equity

+14.4%

Net margin

+6.5%

Market value

9.9 bn USD

Quality, value and trend

Where Demant stands against every Nordic stock today. 100 is best.

Quality52

Profitability and a sound balance sheet over time. Better than 52% of Nordic stocks.

Value25

The price measured against earnings, assets and cash flow. Better than 25% of Nordic stocks.

Trend93

The price development over the past year. Better than 93% of Nordic stocks.

Combined59

Quality, value and trend together. Better than 59% of Nordic stocks.

About Demant

Demant A/S is a company in healthcare, listed on Nasdaq Copenhagen. The share trades in DKK. It has around 26,500 employees.

Demant A/S operates as a hearing healthcare company in Europe, North America, Asia, Pacific region, and internationally. It engages in the development, manufacture, and wholesale of hearing aids; owning and operating hearing care clinics; and offers hearing and balance assessment solutions used by audiologists, ENT doctors, and balance clinics. The company was formerly known as William Demant Holding A/S and changed its name to Demant A/S in March 2019. Demant A/S was founded in 1904 and is headquartered in Smørum, Denmark.

See the full analysis in InvestWiser.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

See the full analysis